Research selected as new and noteable by SAMHSA-HRSA

- 0 Comments

BioMed Central is delighted that an article published in Addiction Science & Clinical Practice, has been selected for the New, Notable Integration Research and Resources section of SAMHSA-HRSA Center for Integrated Health Solutions (CIHS).

The SAMHSA-HRSA Center for Integrated Health Solutions (CIHS) aims to promote the development of integrated primary and behavioral health services with the intention of further addressing the needs of individuals with conditions related to mental health and substance use. CIHS collates a variety of new and important research relevant to integrated health services design and provision, consumer experience, and cost.

The authors of ‘Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems,’, Theresa A Rowe (Yale University), Janet S Jacapraro (University of Maryland) and Darius A Rastegar (Johns Hopkins University) conclude that that initiation of office-based buprenorphine treatment in a primary care setting is associated with identification and treatment of other chronic medical problems, suggesting a benefit beyond drug treatment outcomes.

Previous studies on this topic have shown that providing on-site medical care with drug treatment is associated with improved follow-up with care, improved drug outcomes , and a reduction in emergency department use and hospitalization. However, there have been few studies of the medical care of patients engaged in office-based buprenorphine treatment. This study aims to evaluate the identification and treatment of other chronic medical conditions among patients who initiated office-based buprenorphine treatment in an academic primary care practice.

Addiction Science & Clinical Practice provides a forum for clinically relevant research and perspectives that contribute to improving the quality of care for people with unhealthy alcohol, tobacco, or other drug use and addictive behaviours across a spectrum of clinical settings. The unique advantage of Addiction Science & Clinical Practice is its targeted focus on improving quality of care for patients.